Table 7 SLC7A5 protein expression and patient outcome in the combined discovery and validation sets in all cases and in ER-positive high proliferation tumours

SLC7A5

1.001 (1.000–1.003)

0.063

0.126

1.004 (1.001–1.006)

0.006

0.024

Lymph node stage

2.060 (1.813–2.341)

1.7 × 10⁻²⁸

<0.0001

1.756 (1.427–2.161)

1.04 × 10⁻⁷

<0.0001

Size

1.365 (1.111–1.678)

0.003

0.009

1.169 (0.838–1.632)

0.358

0.716

Grade

2.454 (2.023–2.977)

1.8 × 10⁻²⁰

<0.0001

1.756 (1.154–2.672)

0.009

0.027